Azee — Research Summary
Azee 250mg is a macrolide antibiotic compound manufactured by Cipla containing 250mg azithromycin for laboratory research applications. This pharmaceutical-grade compound enables researchers to investigate antimicrobial mechanisms, bacterial resistance patterns, and macrolide pharmacokinetics in controlled laboratory settings. Scientists studying infectious disease pathways can examine azithromycin’s binding affinity to bacterial ribosomal subunits and its broad-spectrum antimicrobial properties. The compound provides standardised reference material for microbiological assays, susceptibility testing protocols, and antibiotic resistance gene expression studies. Researchers at Stroid UK Shop utilise azithromycin compounds to analyse bacterial protein synthesis inhibition and therapeutic resistance mechanisms.
Laboratory Applications
Laboratory studies examine azithromycin’s mechanism of action through binding to the 50S ribosomal subunit, effectively inhibiting bacterial protein synthesis in gram-positive and gram-negative bacterial cultures. Researchers investigate the compound’s tissue penetration characteristics, extended half-life properties, and post-antibiotic effects in various experimental models. Microbiological research focuses on minimum inhibitory concentration determinations, time-kill curve analyses, and synergistic interactions with other antimicrobial agents. Scientists studying respiratory pathogen research can evaluate azithromycin’s activity against common bacterial isolates including Streptococcus pneumoniae, Haemophilus influenzae, and atypical organisms. The compound serves as reference standard for developing novel macrolide derivatives and investigating antimicrobial resistance mechanisms. Research applications extend to pharmacokinetic studies, biofilm formation inhibition, and anti-inflammatory property investigations. Studies examining selective receptor modulation benefit from standardised pharmaceutical controls. Comparative analyses with bioactive peptide compounds provide valuable research insights.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Azithromycin |
| Strength | 250mg |
| Manufacturer | Cipla |
| CAS Number | 83905-01-5 |
| Molecular Formula | C₃₈H₇₂N₂O₁₂ |
| Molecular Weight | 749.00 g/mol |
| Storage | Room temperature, dry environment |
| Classification | Macrolide antibiotic |
Research Compliance
This azithromycin research compound is manufactured by Cipla exclusively for in-vitro laboratory research purposes and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. Researchers must ensure proper laboratory protocols, safety procedures, and regulatory compliance when handling this research material. Suitable for antimicrobial research, bacterial susceptibility studies, and pharmaceutical development applications only.
